Skip to main content
Watch Insiders
BLTEHealthcare

Belite Bio Inc ADR (BLTE) Insider Trading

In the last 90 days, 3 Belite Bio Inc ADR (BLTE) insiders reported no open-market purchases and 5 sales totaling $32,100,750. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 1, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 1, 2026Hendrik Peter SchollChief Medical OfficerSale500$165.32$82,659
Sep 8, 2026Yu-Hsin LinChief Executive OfficerSale100,435$190.00$19,082,550
Sep 8, 2026Hao-Yuan ChuangChief Financial OfficerSale67,395$189.98$12,803,527
Aug 12, 2026Hao-Yuan ChuangChief Financial OfficerSale367$180.35$66,187
Aug 12, 2026Yu-Hsin LinChief Executive OfficerSale365$180.35$65,827
Jun 18, 2026Hendrik Peter SchollChief Medical OfficerSale10,000$145.24$1,452,435
Jun 16, 2026Hendrik Peter SchollChief Medical OfficerSale10,000$140.57$1,405,729
May 7, 2026Nathan L. MataChief Scientific OfficerSale666$153.21$102,039
May 6, 2026Nathan L. MataChief Scientific OfficerSale1,000$153.84$153,839
May 5, 2026Nathan L. MataChief Scientific OfficerSale1,000$155.50$155,503
🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

BLTE insider trading FAQ

Are BLTE insiders buying or selling?
Over the last 90 days, BLTE insiders were net sellers, reporting $0.00 of open-market purchases and $32,100,750 of sales.
When was the last BLTE insider purchase?
No open-market insider purchase of Belite Bio Inc ADR stock was reported in the last 90 days.
Where does BLTE insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Belite Bio Inc ADR officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.